Responsible Member of the Russian Academy of Sciences Alexander Suvorov, Head of the Molecular Microbiology Department of the Institute of Experimental Medicine (IEM) and the Head of the Laboratory of Molecular Genetics of Pathogenic Microorganisms, said that scientists from the Institute of Experimental Medicine are working on the mucous membrane. flu vaccine. It has been reported DEA News.
According to Suvorov, preclinical trials of the vaccine are now being done on laboratory animals. Full-scale preclinical studies can be done if funding is available.
“We have options (vaccines – socialbites.ca) based on neurominidase, there is hemagglutinin. Both turned out to be very good. Therefore, we will have to choose or use both options, ”explained Suvorov.
Previously reportedwhere scientists evaluated the impact of the COVID-19 vaccine on the risk of sudden hearing loss.
Prior to this, a large study found an increased risk of sudden sensorineural hearing loss after being vaccinated against COVID-19 with the Pfizer-BioNTech vaccine.